Clinical trial
A Phase II Study Investigating Upfront Pazopanib In Metastatic Clear Cell Renal Cancer (Panther)
NCT01512186 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study Investigating Upfront Pazopanib In Metastatic Clear Cell Renal Cancer (Panther)
- Lead sponsor
- Queen Mary University of London
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 31, 2010
- Completion date
- December 31, 2014
- Enrollment
- 95 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic clear cell renal cancer